相关实验视频

Updated: Jun 12, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

血清GDF-15的诊断价值在患有状形瘤的患者中

Bing Wang¹, Jie Zhang¹, Ruiqing Ma²

¹Department of Clinical Laboratory of Aerospace Center Hospital, Beijing 100049, China.

Clinical biochemistry

|September 20, 2024

概括

血清生长差异化因子15 (GDF-15) 显示出作为Pseudomyxoma peritonei (PMP) 的诊断标记物的前景. 将GDF-15与碳水化合物抗原125 (CA125) 结合起来,可显著提高PMP的诊断准确性.

科学领域:

在瘤学瘤学.
生物化学生物化学
医学诊断医学诊断医学诊断

背景情况:

皮瘤 (Pseudomyxoma peritonei,简称PMP) 是一种罕见的恶性瘤,具有有限的诊断生物标志物.
由于缺乏敏感和特定的血清标记物,准确诊断PMP是具有挑战性的.
需要新的血清标记物来改善PMP诊断和患者管理.

研究的目的:

研究血清生长分化因子15 (GDF-15) 在PMP患者的诊断效用.
评估GDF-15作为潜在的PMP诊断生物标志物.
为了比较GDF-15单独和与CA125.5结合的诊断性能.

主要方法:

一个1: 1匹配的病例对照研究与44名PMP患者和44名健康对照进行.
使用ELISA测量血清GDF-15度.使用ELISA测量血清GDF-15度.使用ELISA测量血清GDF-15度.
用接收器操作特征 (ROC) 曲线分析来评估诊断价值.

主要成果:

在PMP患者中,血清GDF-15水平明显高于对照组 (中位数为1192.77 pg/mL) (中位数为533.27 pg/mL) (P<0.001).
GDF-15显示了PMP的良好诊断性能,其AUC为0.907,93.18%的灵敏度和77.27%的特异性.
GDF-15和CA125的组合产生了更大的AUC (P=0.027),敏感度为86.36%,特异性为95.45%.

结论:

血清GDF-15具有作为PMP的新型诊断标记物的潜力.
将GDF-15与CA125结合起来,与单独使用GDF-15相比,为PMP提供了更好的诊断性能.
GDF-15水平与年龄相关,这表明PMP患者的潜在年龄相关变化.

关键词:

细胞减少的完整性细胞减少的完整性这是GDF-15的GDF-15.伪瘤 (Pseudomyxoma peritonei) 是一种可能导致瘤的疾病.

更多相关视频

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Published on: December 9, 2022

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

相关概念视频

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...